Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Seeing Machines secures major UK bus contract as demand picks up

(Sharecast News) - Shares in AIM-listed Seeing Machines rose on Friday after the AI-powered operator monitoring systems group announced a "significant" five-year agreement with an unnamed UK bus manufacturer. The contract will see Seeing Machines deliver its Guardian Generation 3 preventative driver safety solution - which uses computer vision and machine learning to mitigate driver mistakes - to buses after manufacture across Europe.

The company said the deal will support sales for the unnamed OEM as the General Safety Regulation mandate for Advanced Driver Distraction Warning comes into force.

The UK OEM has already. installed around 200 vehicles with the tech, and makes over 1,700 units a year.

Meanwhile, Seeing Machines said homologation (the process of obtaining official approval from authorities) is currently underway with a further four commercial vehicle OEMs across Europe, representing a potential volume of 4,000 vehicles per annum.

The company also highlighted recent momentum in the demand for the Guardian tech from the oil and gas sectors across Europe, and bus, rail and tram markets in the UK.

"Collectively, these developments represent substantive recurring commercial opportunities, with the potential for a significant number of Guardian units to be deployed annually," the company said.

"This underscores the strong regional commitment to road safety and reflects the industry's ongoing push to enhance protection for both operators and passengers throughout Europe and the UK."

Seeing Machines shares were up 5.7% at 2.63p by 0921 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.